Exact Sciences Corporation (EXAS)

Basic

  • Market Cap

    $12.12B

  • EV

    $13.96B

  • Shares Out

    180.85M

  • Revenue

    $2,405.88M

  • Employees

    6,350

Margins

  • Gross

    73.83%

  • EBITDA

    -5.99%

  • Operating

    -14.38%

  • Pre-Tax

    -11.69%

  • Net

    -11.73%

  • FCF

    -0.98%

Returns (5Yr Avg)

  • ROA

    -7.45%

  • ROE

    -24.1%

  • ROCE

    -13.12%

  • ROIC

    -23.66%

Valuation (TTM)

  • P/E

    —

  • P/B

    —

  • EV/Sales

    —

  • EV/EBITDA

    —

  • EV/FCF

    —

  • EV/Gross Profit

    —

Valuation (NTM)

  • Price Target

    $90.02

  • P/E

    —

  • EV/Sales

    —

  • EV/EBITDA

    —

  • EV/FCF

    —

Per Share

  • Rev

    $13.42

  • Earnings (Dil)

    -$1.57

  • FCF

    -$0.13

  • Book Value

    $17.26

Growth (CAGR)

  • Rev 3Yr

    22.13%

  • Rev 5Yr

    43.25%

  • Rev 10Yr

    88.97%

  • Dil EPS 3Yr

    -10.92%

  • Dil EPS 5Yr

    5.99%

  • Dil EPS 10Yr

    7.9%

  • Rev Fwd 2Yr

    16.42%

  • EBITDA Fwd 2Yr

    —

  • EPS Fwd 2Yr

    —

  • EPS LT Growth Est

    20%

Dividends

  • Yield

    —

  • Payout

    —

  • DPS

    —

  • DPS Growth 3Yr

    —

  • DPS Growth 5Yr

    —

  • DPS Growth 10Yr

    —

  • DPS Growth Fwd 2Yr

    —

Select a metric from the list below to chart it

Dec '13
Dec '15
Dec '17
Dec '19
Dec '21
LTM
Metric
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
LTM

Total Revenues

454.5

876.3

1,491.4

1,767.1

2,084.3

2,405.9

Total Revenues % Chg.

70.9%

92.8%

70.2%

18.5%

17.9%

20.0%

Cost of Goods Sold, Total

116.6

216.7

354.3

458.8

574.4

629.5

Gross Profit

337.8

659.6

1,137.1

1,308.3

1,509.9

1,776.3

Selling General & Admin Expenses, Total

427.5

737.6

1,071.3

1,516.2

1,639.9

1,625.4

R&D Expenses

67.3

139.7

554.1

385.6

393.4

405.2

Amortization of Goodwill and Intangible Assets

2.5

16.0

93.4

95.0

97.5

91.8

Other Operating Expenses, Total

497.3

893.4

1,718.8

1,996.8

2,130.8

2,122.4

Operating Income

-159.5

-233.8

-581.7

-688.5

-620.9

-346.1

Interest Expense, Total

-36.8

-199.2

-67.9

-18.6

-19.6

-17.0

Interest And Investment Income

21.2

26.5

6.6

31.8

—

7.4

Net Interest Expenses

-15.6

-172.7

-61.4

13.2

-19.6

-9.6

EBT, Excl. Unusual Items

-175.1

-406.4

-643.1

-675.3

-640.5

-355.7

Merger & Related Restructuring Charges

—

—

—

-140.6

—

—

Gain (Loss) On Sale Of Investments

—

—

—

—

-19.4

-5.6

Gain (Loss) On Sale Of Assets

—

—

—

—

-13.2

—

Asset Writedown

—

—

-209.7

-20.2

-16.0

-4.1

Other Unusual Items

—

—

23.7

-6.4

56.6

84.1

EBT, Incl. Unusual Items

-175.1

-406.4

-829.1

-842.5

-632.6

-281.3

Income Tax Expense

0.1

-193.4

-5.5

-246.9

-9.1

0.8

Earnings From Continuing Operations

-175.1

-213.1

-823.6

-595.6

-623.5

-282.1

Net Income

-175.1

-213.1

-823.6

-595.6

-623.5

-282.1

Net Income to Common Incl Extra Items

-175.1

-213.1

-823.6

-595.6

-623.5

-282.1

Net Income to Common Excl. Extra Items

-175.1

-213.1

-823.6

-595.6

-623.5

-282.1

Total Shares Outstanding

123.2

147.6

159.4

173.7

177.9

180.8

Weighted Avg. Shares Outstanding

122.2

131.3

151.1

171.3

176.4

179.3

Weighted Avg. Shares Outstanding Dil

122.2

131.3

151.1

171.3

176.4

179.3

EPS

-1.4

-1.6

-5.4

-3.5

-3.5

-1.6

EPS Diluted

-1.4

-1.6

-5.4

-3.5

-3.5

-1.6

EBITDA

-136.4

-183.5

-418.3

-508.2

-423.4

-144.2